Paper · 42959035
Behavioral-metabolic phenotypes and differential risks of diabetic kidney disease and peripheral neuropathy in type 2 diabetes: a latent class analysis.
Wang Y and 8 others. Front Endocrinol (Lausanne), 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Behavioral-metabolic phenotypes and differential risks of diabetic kidney disease and peripheral neuropathy in type 2 diabetes: a latent class analysis. Papers, record 42959035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42959035
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Behavioral-metabolic phenotypes and differential risks of diabetic kidney disease and peripheral neuropathy in type 2 diabetes: a latent class analysis.
- Journal
- Front Endocrinol (Lausanne)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-31
Source PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Nephropathies | Major topic |
| Diabetic Neuropathies | Major topic |
| Humans | |
| Female | |
| Latent Class Analysis | |
| Male | |
| Phenotype | |
| Risk Factors | |
| Middle Aged | |
| Obesity | |
| Aged | |
| Life Style |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32,290,082 | Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32290082 | PubMed |
| 2 | 34,639,176 | Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)-New Aspects. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34639176 | PubMed |
| 3 | 38,695,216 | Investigating the causal association of generalized and abdominal obesity with microvascular complications in patients with type 2 diabetes: A community-based prospective study. | Diabetes Obes Metab | 2024 | https://conductscience.org/library/papers/38695216 | PubMed |
| 4 | 40,274,830 | Diabetic neuropathy: cutting-edge research and future directions. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40274830 | PubMed |
| 5 | 36,507,646 | 6. Glycemic Targets: Standards of Care in Diabetes-2023. | Diabetes Care | 2023 | https://conductscience.org/library/papers/36507646 | PubMed |
| 6 | 36,909,323 | Visceral fat correlates with insulin secretion and sensitivity independent of BMI and subcutaneous fat in Chinese with type 2 diabetes. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/36909323 | PubMed |
| 7 | 28,522,654 | Diabetic Kidney Disease: Challenges, Progress, and Possibilities. | Clin J Am Soc Nephrol | 2017 | https://conductscience.org/library/papers/28522654 | PubMed |
| 8 | 28,608,806 | Targeting Overconsumption of Sugar-Sweetened Beverages vs. Overall Poor Diet Quality for Cardiometabolic Diseases Risk Prevention: Place Your Bets! | Nutrients | 2017 | https://conductscience.org/library/papers/28608806 | PubMed |
| 9 | 33,731,778 | Normal weight obesity and the risk of diabetes in Chinese people: a 9-year population-based cohort study. | Sci Rep | 2021 | https://conductscience.org/library/papers/33731778 | PubMed |
| 10 | 38,867,282 | Combined associations of visceral adipose tissue and adherence to a Mediterranean lifestyle with T2D and diabetic microvascular complications among individuals with prediabetes. | Cardiovasc Diabetol | 2024 | https://conductscience.org/library/papers/38867282 | PubMed |
1 to 10 of 46
See all 46 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42959035
GET https://conductscience.org/api/papers/v1/42959035/references?page=2